Accessibility Menu
 
Ezz Life Science logo

Ezz Life Science

(ASX) EZZ

Current Price$0.83
Market Cap$39.28M
Since IPO (2021)-20%
5 Year+8%
1 Year-35%
1 Month-21%

Ezz Life Science Financials at a Glance

Market Cap

$39.28M

Revenue (TTM)

$136.44M

Net Income (TTM)

$11.91M

EPS (TTM)

$0.06

P/E Ratio

13.62

Dividend

$0.04

Beta (Volatility)

0.03 (Low)

Price

$0.83

Volume

0

Open

$0.84

Previous Close

$0.83

Daily Range

$0.83 - $0.85

52-Week Range

$0.76 - $3.38

EZZ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ezz Life Science

Industry

Personal Products

CEO

Qi Zhou Qin

Headquarters

Lidcombe, NSW 2128, AU

EZZ Financials

Key Financial Metrics (TTM)

Gross Margin

68%

Operating Margin

13%

Net Income Margin

5%

Return on Equity

11%

Return on Capital

29%

Return on Assets

9%

Earnings Yield

7.34%

Dividend Yield

0.05%

Payout Ratio

63.89%

Stock Overview

Market Cap

$39.28M

Shares Outstanding

47.04M

Volume

0

Short Interest

0.00%

Avg. Volume

27.50K

Financials (TTM)

Gross Profit

$49.72M

Operating Income

$9.93M

EBITDA

$11.10M

Operating Cash Flow

$4.35M

Capital Expenditure

$260.88K

Free Cash Flow

$4.09M

Cash & ST Invst.

$20.85M

Total Debt

$304.49K

Ezz Life Science Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$24.82M

+14.4%

Gross Profit

$15.54M

+6.8%

Gross Margin

62.63%

N/A

Market Cap

$39.28M

N/A

Market Cap/Employee

$3.57M

N/A

Employees

11

N/A

Net Income

$641.30K

-156.1%

EBITDA

$137.43K

-92.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$13.35M

+8.4%

Accounts Receivable

$7.07M

+115.8%

Inventory

$3.73M

+139.2%

Long Term Debt

$0.00

N/A

Short Term Debt

$123.86K

-59.3%

Return on Assets

8.87%

N/A

Return on Invested Capital

28.60%

N/A

Free Cash Flow

$5.52M

-1272.8%

Operating Cash Flow

$5.50M

-1549.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PCK.AXPainChek Limited
$0.15+3.45%
IMU.AXImugene Limited
$0.14-6.67%
BIO.AXBiome Australia Limited
$0.34+2.99%
ILA.AXIsland Pharmaceuticals Limited
$0.37+1.37%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
NOKNokia
$9.46-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.44-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$49.17+0.00%

Questions About EZZ

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.